AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: CORT
Report Date: 2026-07-30
Full Report: https://amaly.io/stock/CORT

EXECUTIVE SUMMARY
------------------
Compliance Status: COMPLIANT
Quality Rating: AAA
Description: Corcept Therapeutics Incorporated (CORT) is a biopharmaceutical company specializing in cortisol-modulating therapies. This report evaluates its Shariah compliance across financial, business activity, ESG, and multi-perspective criteria. Overall, CORT demonstrates strong compliance, supported by inclusion in all major Shariah indices and favorable financial ratios. Minor purification is required for interest income, but no disqualifying factors are present.

Primary Compliance Concerns:
- Minor interest income requiring 3.64% purification

Purification Requirement: 3.64%
Index Inclusion: Included in all major Shariah indices: S&P Dow Jones, MSCI Islamic, FTSE Shariah, and Dow Jones Islamic Market (DJIM)

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 0.0%
Interest Income Ratio: 0.0%
Purification Required: 3.64%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: INCLUDED
MSCI Islamic: INCLUDED
DJIM: INCLUDED
FTSE Shariah: INCLUDED
Total: 4 of 4
Last Verified: 2025-12-31

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-21T00:00:00Z

---
Full interactive report: https://amaly.io/stock/CORT
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.